Ultra-luxury travelers can enjoy a complimentary two-category suite upgrade or up to $2,000 in shipboard credit on select ...

Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that includes a $50 million ...

Explore neighborhoods outside the Aurelian Walls, eat bucatini all’amatriciana at the restaurant that introduced it to Rome, ...

The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...

This year, the renowned tour operator will open Wilderness Magashi Peninsula in ... and Aman is coming for the Dolomites.

Whether high-octane or spirit-free, cocktails demand sustenance. Cantina Rosa delivers a hearty teaser tour of Mexico’s regional botanas (a.k.a. snacks). The cocktail de camarones packs plump ...

The Bookseller’s Hotlists are literary agencies’ top manuscripts out on submission with UK and international publishers, ...

BOSTON, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today ...